From Biomarkers to Treatment: The New Need-to-Know in Early Breast Cancer

Learn from expert faculty as they discuss emerging biomarkers and other recent data changing practice in early breast cancer including a downloadable slideset from a satellite symposium an on-demand webcast and expert commentary.

Share

Program Content

Activities

HR+ and/or g<i>BRCA</i>m+ EBC
Updates in High-Risk HR+ and/or gBRCAm+ Early-Stage Breast Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 03, 2022

Expires: June 02, 2023

IO for Early TNBC
Role of Immunotherapy for Early-Stage Triple-Negative Breast Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 03, 2022

Expires: June 02, 2023

Future Directions in EBC
Clinical Challenges and Future Directions in Early-Stage Breast Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 03, 2022

Expires: June 02, 2023

Activities

EBC: Biomarkers to Treatment
From Biomarkers to Treatment: The New Need-to-Know in Early Breast Cancer
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: June 08, 2022

Expires: June 07, 2023

Activities

EBC Recent Developments
An Expert Tour of Recent Developments in Early-Stage Breast Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 04, 2022

Expires: August 03, 2023

Faculty

cover img faculity

Heather McArthur, MD, MPH

Associate Professor
Department of Internal Medicine
Clinical Director, Breast Cancer Program
Komen Distinguished Chair in Clinical Breast Cancer Research
UT Southwestern Medical Center
Dallas, Texas

cover img faculity

Jennifer K. Litton, MD

Associate Professor of Medicine
Department of Breast Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Rita Nanda, MD

Associate Professor of Medicine
Director, Breast Oncology
Section of Hematology/Oncology
Department of Medicine
The University of Chicago
Chicago, Illinois

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Lilly

Merck Sharp & Dohme Corp.